Smith & Nephew has launched its Werewolf Flow 90 Wand with Flow~IQ technology in the U.S.
The wand is designed to be used in the shoulder and is indicated for use on all soft tissues. It was developed to be used in conjunction with the Werewolf Coblation system.
Smith & Nephew’s coablation technology has shown in a level 1 randomized controlled trial that it has faster patient recovery times with better long-term patient outcomes compared to other mechanical debridement in the knee, according to the company.
“Flow 90 was fantastic. It excels at rapid bulk tissue removal while remaining very precise. FLOW 90’s triangular tip also enables you to do excellent dissection,” Scott Trenhaile, assistant professor at Rush University Medical Center, said in a press release. “This combination of speed, control and dissection is unmatched by any other radio-frequency device, and is an exciting addition to the Smith & Nephew portfolio.”
The coablation technology creates and applied energy fields known as glow discharge plasma to ablate molecules in the tissue. The technology operates at lower temperatures than other radio frequency-based technologies for precise removal of soft tissues with little damage to untargeted tissue.